Resistance to b-lactams is commonly achieved via b-lactamase enzymes that inactivate the pharmacophore by hydrolyzing its b-lactam ring, rendering the antibiotic inert.67 To salvage efficacy of these drugs, b-lactams are commonly coformulated with a b-lactamase inhibitor, (e.g. Augmentin; ...